Hymovis 24 mg/3 ml, 2 ampoules, Fidia Farmaceutici

Hymovis 24 mg/3 ml, 2 ampoules, Fidia Farmaceutici

Properties:
Hymovis is indicated for the treatment of pain in joints affected by arthrosis and for improving joint mobility by increasing the viscoelasticity of the synovial fluid.

Composition:
Main component: Hyadd4 (sodium hyaluronate hexadecylamide), 24 mg / 3 ml.
Other components: Sodium chloride, disodium acid phosphate dodecahydrate, sodium diacid phosphate dihydrate, water for injections. Main component: Hyadd4 (sodium hyaluronate hexadecylamide), 24 mg/3 ml.
Other components: sodium chloride, disodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, water for injections.

Dosage and administration:
HYMOVIS is intended for intra-articular injection only. The administration of the product must be carried out exclusively by doctors.
Also, the sterility of the outer surface of the syringe allows the intra-articular injection to be performed in the operating room as well.
Given the viscosity of the solution, HYMOVIS should be injected slowly into the affected joint using a suitable sterile needle (18 G or 20 G).
All rules regarding aseptic administration technique must be strictly observed. Remove any excess fluid from the joint, if present, before injecting HYMOVIS.
Dosage
A treatment cycle for arthritic joints consists of two injections administered at an interval of one week.
A course of treatment for a joint with a meniscus injury consists of two injections given at two-week intervals.

The contents of the syringe are sterilized using steam.
Keep the product out of the reach of children.

Presentation:
2 pre-filled syringes, 24 mg/3 ml HYMOVIS is a medical device.